Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoLike other early-stage biotech companies, Gyre has reported years of annual losses, though came in...
7 F-Rated Stock Picks to Avoid Like the Plague in May
InvestorPlace· 7 days agoThe stock market is off to a washing machine kind of start for 2024, with gains and lulls that keep...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
Earn $1000 Every Month From These 3 Stocks
Motley Fool via Yahoo Finance· 5 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of May 6, 2024 Mark Roussin, CPA has...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 14 hours agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam? - Pfizer...
Benzinga· 4 days agoTesla CEO Elon Musk seems to think biopharma giant Pfizer, Inc. PFE has dodged taxes despite high...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 3 days agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Moderna. The...
Microsoft asks AI employees in China to relocate amid tensions between the U.S. and China
Quartz· 8 hours agoMicrosoft is reportedly asking hundreds of its employees in China to consider relocating outside of...
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
Benzinga via AOL· 6 days agoIt's been a quiet week in the markets, marked by a dearth of major economic news and a consistent...
One stock is dragging down the S&P 500's earnings growth
AOL· 3 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month ...
